Lown Right Care
Reducing Overuse and Underuse

Routine Vitamin D Testing: Unnecessary and Ineffective

Andy Lazris, MD, CMD
Alan Roth, DO
Patient perspective by Helen Haskell
John James

American Family Physician. 2024;110(3):302-304.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

CASE SCENARIO

A 65-year-old, health-conscious man reports that he eats organic food and exercises regularly. He often asks his family physician for blood tests to assess for “silent abnormalities.” He applies sunscreen whenever he goes outdoors, and at his wellness visit, he asks for a vitamin D test after reading that sunscreen blocks its production in the skin. He takes 1,000 IU of vitamin D3 as part of a daily multivitamin. His 25-hydroxyvitamin D level is 27 ng per mL (70 nmol per L). [corrected] Although his primary care physician informed him that levels greater than 20 ng per mL (50 nmol per L) are considered adequate for 97.5% of the population, the patient decided to increase his daily vitamin D dose to 5,000 IU and insisted on more frequent checks, every 4 months, until the levels exceed 50 ng per mL (125 nmol per L). [corrected]

His physician explained that high vitamin D levels can be dangerous and that his current dose and level were more than adequate. The patient consulted another clinician who agreed to continue his preferred testing schedule. When the patient presented to his primary care physician 1 year later, he was taking 10,000 IU of vitamin D per day, and his 25-hydroxyvitamin D level was 85 ng per mL (210 nmol per L). [corrected]

CLINICAL COMMENTARY

Vitamin D Testing Escalation

Over the past 10 years, vitamin D testing has increased worldwide.15 Up to 75% of vitamin D testing is unnecessary, something many researchers have discussed.6,7 Testing is often patient-driven, promoted in the mass media based on flawed observational data, and performed for inappropriate reasons such as general fatigue.2,8 The number of vitamin D tests in the United States reimbursed by Medicare Part B increased 83-fold between 2000 and 2010, with many ordered by family physicians.7,9 The cost of inappropriate testing is estimated at £2 million ($2.5 million) per year and $800 million per year in excess Medicare costs.2,10 These estimates do not account for downstream costs because abnormal vitamin D test results can result in a cascade of referrals, radiologic tests, and subsequent vitamin D and other laboratory tests.10

The Value of Vitamin D Supplementation

For years, observational studies suggested a strong correlation between low vitamin D levels and multiple disease states. This led to an assumption of cause and effect between vitamin D and illness and resulted in the initiation of more rigorous randomized studies to evaluate the clinical benefits of vitamin D supplementation. None of these trials were designed to assess the value of vitamin D assessment as a screening test; instead, they measured levels, gave participants supplements or placebo, and then measured outcomes. Baseline vitamin D levels varied across studies, and many studies did not stratify outcomes between patients with very low starting levels and those with higher starting levels. To complicate interpretation, many participants were taking supplements before joining the studies.

The results of these studies are summarized in the U.S. Preventive Services Task Force (USPSTF) 2015 and 2021 recommendation statements and in review articles.3,1014 As one article noted, “In almost every trial, various doses and routes of administration did not show efficacy of vitamin D in preventing fractures, falls, cancer, cardiovascular disease, type 2 diabetes mellitus, asthma, and respiratory infections.”13

ANDY LAZRIS, MD, CMD, is a family physician at Personal Physician Care, Columbia, Maryland.

ALAN ROTH, DO, FAAFP, FAAHPM, is a family physician at Jamaica Hospital Medical Center, Jamaica, New York.

Address correspondence to Andy Lazris, MD, CMD, at alazris50@gmail.com.

Author disclosure: No relevant financial relationships.

  1. 1.Crowe FL, Jolly K, MacArthur C, et al. Trends in the incidence of testing for vitamin D deficiency in primary care in the UK: a retrospective analysis of The Health Improvement Network (THIN), 2005–2015. BMJ Open. 2019;9(6):e028355.
  2. 2.Woodford HJ, Barrett S, Pattman S. Vitamin D: too much testing and treating?. Clin Med (Lond). 2018;18(3):196-200.
  3. 3.LeFevre ML. Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;162(2):133-140.
  4. 4.Sattar N, Welsh P, Panarelli M, et al. Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet. 2012;379(9811):95-96.
  5. 5.Bilinski K, Boyages S. The rise and rise of vitamin D testing. BMJ. 2012;345:e4743.
  6. 6.Singer AG, McChesney C. Reduce unnecessary routine vitamin D testing. Can Fam Physician. 2023;69(9):620-622.
  7. 7.Rodd C, Sokoro A, Lix LM, et al. Increased rates of 25-hydroxy vitamin D testing: dissecting a modern epidemic. Clin Biochem. 2018;59:56-61.
  8. 8.McChesney C, Singer A, Duquette D, et al. Do not routinely test for vitamin D. BMJ. 2022;378:e070270.
  9. 9.Lin KW. Vitamin D screening and supplementation in primary care: time to curb our enthusiasm. Am Fam Physician. 2018;97(4):226-227.
  10. 10.Rockwell MS, Wu Y, Salamoun M, et al. Patterns of clinical care subsequent to nonindicated vitamin D testing in primary care. J Am Board Fam Med. 2020;33(4):569-579.
  11. 11.Amrein K, Scherkl M, Hoffmann M, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020;74(11):1498-1513.
  12. 12.Giustina A, Bouillon R, Binkley N, et al. Controversies in vitamin D: a statement from the third international conference. JBMR Plus. 2020;4(12):e10417.
  13. 13.Gallagher JC, Rosen CJ. Vitamin D: 100 years of discoveries, yet controversy continues [published correction appears in Lancet Diabetes Endocrinol. 2023; 11(6): e8]. Lancet Diabetes Endocrinol. 2023;11(5):362-374.
  14. 14.Kahwati LC, LeBlanc E, Weber RP, et al. Screening for Vitamin D deficiency in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021;325(14):1443-1463.
  15. 15.LeBoff MS, Chou SH, Ratliff KA, et al. Supplemental vitamin D and incident fractures in midlife and older adults. N Engl J Med. 2022;387(4):299-309.
  16. 16.Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, et al. Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern Med. 2016;176(2):175-183.
  17. 17.LeFevre ML, LeFevre NM. Vitamin D screening and supplementation in community-dwelling adults: common questions and answers. Am Fam Physician. 2018;97(4):254-260.
  18. 18.Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2014(1):CD007470.
  19. 19.Brenner H, Jansen L, Saum KU, et al. Vitamin D supplementation trials aimed at reducing mortality have much higher power when focusing on people with low serum 25-hydroxyvitamin D concentrations. J Nutr. 2017;147(7):1325-1333.
  20. 20.Arboleya L, Braña I, Pardo E, et al. Osteomalacia in adults: a practical insight for clinicians. J Clin Med. 2023;12(7):2714.

Lown Institute Right Care Alliance is a grassroots coalition of clinicians, patients, and community members organizing to make health care institutions accountable to communities and to put patients, not profits, at the heart of health care.

This series is coordinated by Kenny Lin, MD, MPH, deputy editor.

A collection of Lown Right Care published in AFP is available at https://www.aafp.org/afp/rightcare.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.